Drug abuse and dependency during pregnancy: Anaesthetic issues

Anaesthesia and Intensive Care

Volumn 35, Issue 6, 2007, Pages 881-893

  Ludlow, J ^a   Christmas, T ^b   Paech, M J ^b,c   Orr, B ^a,d  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b KING EDWARD MEMORIAL HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Drug abuse; Drug dependency; Obstetric anaesthesia; Pregnancy

Indexed keywords

OPIATE;

CESAREAN SECTION; DRUG ABUSE; DRUG DEPENDENCE; GENERAL PRACTITIONER; HUMAN; OBSTETRIC ANESTHESIA; OBSTETRIC CARE; PAIN; PATIENT CARE; PREGNANCY; PRENATAL CARE; REVIEW; VAGINAL DELIVERY;

EID: 37049024974     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0703500605     Document Type: Review

References (87)

1. Roberts DM, Meyer-Witting M. High-dose buprenorphine: perioperative precautions and management strategies. Anaesth Intensive Care 2005; 33:17-25.
2. Kuczkowski KM. Labor analgesia for the drug abusing parturient: is there cause for concern? Obstet Gynecol Surv 2003; 58:599-608.
3. Cassidy B, Cyna AM. Challenges that opioid-dependent women present to the obstetric anaesthetist. Anaesth Intensive Care 2004; 32:494-501.
4. Kuczkowski K. Anesthetic implications of drug abuse in pregnancy. J Clin Anesth 2003; 15:382-394.
5. Birnbach DJ, Stein DJ. The substance-abusing parturient: implications for analgesia and anaesthesia management. Balliere's Clin Obstet Gynaecol 1998; 12:443-460.
6. Kain ZN, Rimar S, Barasch PG. Cocaine abuse in the parturient and effects on the fetus and neonate. Anesth Analg 1993; 77:835-845.
7. Scimeca MM, Savage SR, Portenoy R, Lowinson J. Treatment of pain in methadone maintained patients. Mt Sinai J Med 2000; 67:412-422.
8. Roche S, Hughes EW. Pain problems associated with pregnancy and their management. Pain Reviews 1999; 6:239-261.
9. Stimmel B. Basic concepts of dependence, addiction, tolerance and withdrawal. In: Stimmel B, ed. Pain and its Relief without Addiction: Clinical Issues in the Use of Opioids and Other Analgesics. 2nd ed. New York, New York State: Haworth Medical Press 1996; p. 54.
10. Mitra S, Sinatra RS. Perioperative management of acute pain in the opioid-dependent patient. Anesthesiology 2004; 101:212-227.
11. Stimmel B, Kreek MJ. Neurobiology of addictive behaviors and relationship to methadone maintenance. Mt Sinai J Med 2000; 67:375-380.
12. Kuczkowski KM. The cocaine abusing parturient: a review of anesthetic considerations. Can J Anesth 2004; 51:145-154.
13. Ludlow JP, Evans SF, Hulse G. Obstetric and perinatal outcomes in pregnancies associated with illicit substance abuse. Aust N Z J Obstet Gynaecol 2004; 44:302-306.
14. Chasnoff IJ, Landress HJ, Barrett ME. The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida. N Engl J Med 1990; 322:1202-1206.
15. Matera C, Warren WB, Moomjy M, Fink DJ, Fox HE. Prevalence of use of cocaine and other substances in an obstetric population. Am J Obstet Gynecol 1990; 163:797-801.
16. American College of Obstetricians and Gynecologists. Human immunodeficiency virus infections. ACOG Technical Bulletin 1992; p.169.
17. Spence MR, Williams R, DiGregorio GJ, Kirby-McDonnell A, Polanky M. The relationship between recent cocaine use and pregnancy outcome. Obstet Gynecol 1991; 78:326-329.
18. McCalla S, Minkoff HL, Feldman J, Glass L, Valencia G. Predictors of cocaine use in pregnancy. Obstet Gynecol 1992; 79:641-644.
19. Kuczkowski K. Cocaine abuse in pregnancy - anesthetic implications. Int J Obstet Anesth 2002; 11:204-210.
20. Fleming JA, Byck R, Barash PG. Pharmacology and therapeutic applications of cocaine. Anesthesiology 1990; 73:518-531.
21. Lange RA, Hillis LD. Cardiovascular complications of cocaine use. N Engl J Med 2001; 345:351-358.
22. Plessinger MA, Woods JR. Maternal, placental, and fetal pathophysiology of cocaine exposure during pregnancy. Clin Obstet Gynecol 1993; 36:267-278.
23. Kuczkowski K. Caesarean section in a cocaine-intoxicated parturient: regional vs general anaesthesia? (Letter). Anaesthesia 2003; 58:1042-1043.
24. Schindler CW, Tella SR, Erzouki HK, Goldberg SR. Pharmacological mechanisms of cocaine's cardiovascular effects. Drug Alcohol Depend 1995; 37:183-191.
25. Kreek MJ. Cocaine, dopamine and the endogenous opioid system. J Addict Dis 1996; 15:73-96.
26. Ross VH, Moore CH, Pan PH, Fragneto RY, James RL, Justis GB. Reduced duration of intrathecal sufentanil analgesia in laboring cocaine users. Anesth Analg 2003; 97:1504-1508.
27. Vertommen JD, Hughes SC, Rosen MA, Shnider SM, Espinoza MI, Messer CP et al. Hydralazine does not restore uterine blood flow during cocaine-induced hypertension in the pregnant ewe. Anesthesiology 1992; 76:580-587.
28. Birnbach DJ. Cardiovascular disease in the pregnant patient: a new risk factor. Cardiovasc Risk Fact 1994; 4:28-33.
29. Boylan JF, Cheng DC, Sandler AN, Carmichael FJ, Koren G, Feindel C et al. Cocaine toxicity and isoflurane anesthesia: hemodynamic, myocardial, metabolic and regional blood flow effects in swine. J Cardiothorac Vasc Anesth 1996; 10:772-777.
30. Murphy JL Jr. Hypertension and pulmonary oedema associated with ketamine administration in a patient with a history of substance abuse. Can J Anaesth 1993; 40:160-164.
31. Jatlow P, Barash PG, van Dyke C, Radding J, Byck R. Cocaine and succinylcholine sensitivity: a new caution. Anesth Analg 1979; 58:235-238.
32. Hollander JE. The management of cocaine-associated myocardial ischaemia. N Engl J Med 1995; 333:1267-1272.
33. Derlet RW, Tseng CC, Albertson TE. Cocaine toxicity and the calcium channel blockers nifedipine and nimodipine in rats. J Emerg Med 1994; 12:1-4.
34. Ashton WB, James MFM, Janicki P, Uys PC. Attenuation of the pressor response to tracheal intubation by magnesium sulphate with and without alfentanil in hypertensive proteinuric patients undergoing caesarean section. Br J Anaesth 1991; 67:741-747.
35. O'Hare R, McAtemney D, Mirakhur RK, Hughes D, Carabine U. Bolus dose remifentanil for control of haemodynamic response to tracheal intubation during rapid sequence induction of anaesthesia. Br J Anaesth 1999; 82:283-285.
36. American Heart Association Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. 8: Advanced challenges in resuscitation. 2: Toxicology in ECC. Circulation 2000; 102:223-228.
37. Ong BH. Hazards to health: dextroamphetamine poisoning. N Engl J Med 1962; 266:130-133.
38. Elliot RH, Rees GB. Amphetamine ingestion presenting as eclampsia. Can J Anesth 1990; 37:130-133.
39. Henry JA, Jeffreys KJ, Dawlings S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine (ecstasy). Lancet 1992; 340:384-387.
40. Samuels SI, Maze A, Albright C. Cardiac arrest in a chronic amphetamine abuser. Anesth Analg 1979; 58:528-530.
41. Michel R, Adams AP. Acute amphetamine abuse: problems during general anaesthesia for neurosurgery. Anaesthesia 1979; 34:1016-1019.
42. Johnston RR, Way WL, Miller RD. Alteration of anesthetic requirement by amphetamine. Anesthesiology 1972; 36:357-363.
43. Kliman L. Drug dependence and pregnancy: antenatal and intrapartum problems. Anaesth Intensive Care 1990; 18:358-360.
44. Stoelting RK. Opioid agonists and antagonists. In: Stoelting RK, ed. Pharmacology and Physiology in Anesthesia Practice. Philadelphia, Pennsylvania: Lippincott 1987; p. 77-112.
45. Koppel BS, Tuchman AJ, Mangiardi JR, Daras M, Weitzner I. Epidural spinal infection in intravenous drug abusers. Arch Neurol 1988; 45:1331-1337.
46. Hughes SC, Dailey PA, Landers D, Dartel BJ, Crombleholme WR, Johnson JL. Parturients infected with human immunodeficiency virus and regional anesthesia: clinical and immunological response. Anesthesiology 1995; 82:32-37.
47. Birnbach DJ. Anesthesia and maternal substance abuse. In: Norris MC, ed. Obstetric Anesthesia. Philadelphia, Pennsylvania: Lippincott 1999; p. 491-499.
48. Wood PR, Soni N. Anaesthesia and substance abuse. . Anaesthesia 1989; 44:672-680.
49. Compton MA. Cold-pressor pain tolerance in opiate and cocaine abusers: correlates of drug type and use status. J Pain Symptom Manage 1994; 9:462-473.
50. Weintraub S, Naulty JS. Acute abstinence syndrome after epidural injection of butorphanol. Anesth Analg 1985; 64:452-453.
51. Gold MS, Pottash AL, Extein I, Kleber HD. Clonidine in acute opiate withdrawal. N Engl J Med 1980; 302:1421-1422.
52. Mehta V, Langford RM. Acute pain management for opioid dependent patients. Anaesthesia 2006; 61:269-276.
53. Ebner N, Rohrmeister K, Winklbaur B, Baewert A, Jaqsch R, Peternell A et al. Management of neonatal abstinence syndrome in neonates born to opioid maintained women. Drug Alcohol Depend 2007; 87:131-138.
54. Hulse G, O'Neil G. Using naltrexone implants in the management of the pregnant heroin user. Aust N Z J Obstet Gynaecol 2002; 42:569-573.
55. Hensl M, Kox WJ. Safety, efficacy and long-term results of a modified version of rapid opiate detoxification under general anaesthesia: a prospective study in methadone, heroin, codeine and morphine addicts. Acta Anaesthesiol Scand 2000; 44:326-333.
56. Press A, Done AK. Solvent sniffing; physiological effects and community control measures. Pediatrics 1967; 39:451-461.
57. Cunningham SR, Dalzell GWN, McGirr P, Khan MM. Myocardial infarction and primary ventricular fibrillation after glue sniffing. Br Med J (Clin Res Ed) 1987; 294:739-740.
58. Grabski DG. Toluene sniffing produces cerebellar degeneration. Am J Psychiatry 1961; 118:461-462.
59. Reyes de la Rocha S, Brown MA, Fortenberry JD. Pulmonary function abnormalities in intentional spray paint inhalation. Chest 1987; 92:100-104.
60. Hersh JH, Podruch PE, Rogers G, Weisskopf B. Toluene embryopathy. J Pediatr 1985; 106:922-927.
61. Prager K, Malin H, Spiegler D, Van Natta P, Placek PJ. Smoking and drinking behaviour before and during pregnancy of married mothers of live-born infants and stillborn infants. Public Health Rep 1984; 99:117-127.
62. Pearce AC, Jones RM. Smoking and anesthesia: preoperative abstinence and perioperative morbidity. Anesthesiology 1984; 61:576-584.
63. Rodkey FI, O'Neal JD, Collison HA. Oxygen and carbon monoxide equilibria of human adult hemoglobin at atmospheric and elevated pressure. Blood 1969; 33:57-65.
64. Ashton CH. Biomedical benefits of cannabinoids. Addict Biol 1999; 4:111-126.
65. Stoelting RK, Martz RC, Gartner J, Creasser C, Brown DJ, Forney RB. Effects of delta 9-tetrahydocannabinol on halothane MAC in dogs. Anesthesiology 1973; 38:521-524.
66. Pertwee RG. Tolerance to and dependence on psychotropic cannabinoids. In: Pratt JA, ed. The Biological Basis of Drug Tolerance and Dependence, New York, New York State: Academic Press 1991; p. 232-263.
67. Mallat A, Roberson J, Brock-Utne JG. Preoperative marijuana inhalation - an airway concern. Can J Anaesth 1996; 43:691-693.
68. Beattie MC, Longabaugh R, Elliott G, Stout RL, Fava J, Noel NE. Effect of the social environment on alcohol involvement and subjective well-being prior to alcohol treatment. J Stud Alcohol 1993; 54:283-296.
69. May JA, White HC, Leonard-White A, Warltier DC, Pagel PS. The patient recovering from alcohol or drug addiction: special issues for the anesthesiologist. Anesth Analg 2001; 92:1601-1608.
70. Swerdlow BN, Holley FO, Maitre PI, Stanski DR. Chronic alcohol intake does not change thiopental anesthetic requirement, pharmacokinetics, or pharmacodynamics. Anesthesiology 1990; 72:455-461.
71. McElhatton PR. The effects of benzodiazepine use during pregnancy and lactation. Reprod Toxicol 1994; 8:461-475.
72. Nicholson K, Balster R. GHB: a new and novel drug of abuse. Drug Alcohol Depend 2001; 63:1-22.
73. Wong C, Chan K, Gibson K, Snead O. Gamma-hydroxybutyric acid: neurobiology and toxicology of a recreational drug. Toxicol Rev 2004; 23:3-20.
74. Gonzalez A, Nutt D. Gamma hydroxy butyrate abuse and dependency. J Psychopharmacol 2005; 19:195-204.
75. Kam P, Yoong F. Gamma-hydroxybutyric acid: an emerging recreational drug. Anaesthesia 1998; 53:1195-1198.
76. Hernandez M, Birnbach D, Van Zundert A. Anesthetic management of the illicit-substance-using patient. Curr Opin Anaesthesiol 2005; 18:315-324.
77. Kissin W, Ball J. The DAWN Report. Drug Abuse Warning Network (DAWN), Office of Applied Studies, Substance Abuse and Mental Health Services Administration (SAMHSA), US Department of Health and Human Services. June 2003.
78. Degenhardt L, Darke S, Dillon P. The prevalence and correlates of gamma-hydroxybutyrate (GHB) overdose among Australian users. Addiction 2003; 98:199-204.
79. Yu B, Wang C, Liu J, Johnson KM, Gallagher JP. Adaptation to chronic PCP results in hyperfunctional NMDA and hypofunctional GABAA synaptic receptors. Neuroscience 2002; 113:1-10.
80. Pal H, Berry N, Kumar R, Ray R. Ketamine dependence. Anaesth Intensive Care 2002; 30:382-384.
81. Mitto K, Darakjian J, Bash J, Murray S, Zogg J, Rawson R. Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal. Am J Addict 2001; 10:232-241.
82. Steadman J, Birnbach D. Patients on party drugs undergoing anesthesia. Curr Opin Anaesthesiol 2003; 16:147-152.
83. Newman L. The chemically dependent parturient. Sem Anesth 1992; 11:66-75.
84. Tjaderborn M, Jonsson A, Hagg S, Ahlner J. Fatal unintentional intoxications with tramadol during 1995-2005. Forensic Sci Int 2007 Mar 8 (e-publication).
85. Freye E, Levy J. Acute abstinence syndrome following abrupt cessation of long-term use of tramadol (Ultram): a case study. Eur J Pain 2000; 4:307-311.
86. Senay EC, Adams EH, Geller A, Inciardi JA, Munoz A, Schnoll SH et al. Physical dependence on Ultram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur. Drug Alcohol Depend 2003; 69:233-241.
87. Adverse Drug Reactions Advisory Committee. Tramadol - four years' experience. Aus Adverse Drug React Bulletin 2003; 22:2.